🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (SHE:002675)
China flag China · Delayed Price · Currency is CNY
11.85
-0.55 (-4.44%)
Nov 20, 2026, 3:04 PM CST

SHE:002675 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
2,6052,7132,8463,2673,5653,897
Other Revenue
28.0528.0523.358.2418.3415.02
2,6332,7412,8693,2763,5833,912
Revenue Growth
-4.24%-4.46%-12.42%-8.58%-8.41%14.42%
Cost of Revenue
1,2571,3561,5211,9222,0512,324
Gross Profit
1,3761,3851,3481,3541,5321,588
Selling, General & Admin
724.05745.12724.93754.41785.29802.41
Research & Development
200.16232.61291.91197.22163.52137.56
Other Operating Expenses
46.4740.7131.7633.8729.1933.34
Operating Expenses
993.31,0331,065980.31980.56974.77
Operating Income
383.15352.17282.61373.77551.72612.99
Interest Expense
-150.73-137.54-96.51-56.76-58.64-56.45
Interest & Investment Income
25.275.175.5612.7813.25.12
Currency Exchange Gain (Loss)
-13.23-13.2315.4415.2542.65-4.08
Other Non Operating Income (Expenses)
-21.55-2.23-2.79-1.17-5.94-2.58
EBT Excluding Unusual Items
222.92204.34204.31343.86542.97555
Impairment of Goodwill
---52.6--80.1-211.26
Gain (Loss) on Sale of Investments
-5.6-15.88-12.92-28.13-39.21-12.15
Gain (Loss) on Sale of Assets
-0.53-0.330.21-0.23-0.38-0.15
Asset Writedown
---33.21---0.16
Other Unusual Items
23.323.3113.3121.7722.324.82
Pretax Income
240.1211.44219.1337.28445.58356.1
Income Tax Expense
56.275777.6883.0792.7595.25
Earnings From Continuing Operations
183.83154.44141.43254.22352.83260.85
Minority Interest in Earnings
26.2741.1942.4-44.48-45.54-109.29
Net Income
210.1195.63183.83209.74307.29151.56
Net Income to Common
210.1195.63183.83209.74307.29151.56
Net Income Growth
26.51%6.42%-12.35%-31.75%102.75%-63.72%
Shares Outstanding (Basic)
821825825825808802
Shares Outstanding (Diluted)
821825825825808802
Shares Change
-0.53%0.01%-0.01%2.10%0.68%0.01%
EPS (Basic)
0.260.240.220.250.380.19
EPS (Diluted)
0.260.240.220.250.380.19
EPS Growth
27.19%6.42%-12.35%-33.15%101.38%-63.73%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
106.88219.03-168.94-235606.93413.42
Free Cash Flow Per Share
0.130.27-0.20-0.280.750.52
Dividend Per Share
0.0810.0810.0800.1250.1500.150
Dividend Growth
168.73%0.78%-36.00%-16.67%0%-40.00%
Gross Margin
52.28%50.52%46.97%41.34%42.77%40.59%
Operating Margin
14.55%12.85%9.85%11.41%15.40%15.67%
Profit Margin
7.98%7.14%6.41%6.40%8.58%3.87%
Free Cash Flow Margin
4.06%7.99%-5.89%-7.17%16.94%10.57%
EBITDA
579.72530.64436.95511.69672.09727.92
EBITDA Margin
22.02%19.36%15.23%15.62%18.76%18.61%
D&A For EBITDA
196.57178.47154.34137.92120.37114.93
EBIT
383.15352.17282.61373.77551.72612.99
EBIT Margin
14.55%12.85%9.85%11.41%15.40%15.67%
Effective Tax Rate
23.44%26.96%35.45%24.63%20.82%26.75%
Revenue as Reported
2,6332,7412,8693,2763,5833,912
Advertising Expenses
-0.420.51.060.830.29